Document:

SERIES
X REDEEMABLE WARRANT AGREEMENT

 

Agreement
made as of [●] between PAVmed Inc., a Delaware corporation, with offices at One Grand Central Place, Suite 4600, New York,
New York 10165 (“Company”), and Continental Stock Transfer & Trust Company, a New York corporation, with offices
at 1 State Street Plaza, 30th Floor, New York, NY 10004 (“Warrant Agent”).

 

WHEREAS,
the Company has previously sold an aggregate of 422,838 Series A Warrants (“Series A Warrants”), each Series A Warrant
evidencing the right of the holder thereof to purchase one share of common stock, par value $0.001 per share (“Common Stock”),
of the Company, to certain private investors; and

 

WHEREAS,
each Series A Warrant is exchangeable for four (4) Series X Redeemable Warrants (“Series X Warrants” or the “Warrants”),
or an aggregate of 1,691,352 Series X Warrants, each Series X Warrant evidencing the right of the holder thereof to purchase one
share of Common Stock of the Company (the “Warrant Shares”); and

 

WHEREAS,
the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection
with the issuance, registration, transfer, exchange, redemption and exercise of all of the Series X Warrants; and

 

WHEREAS,
the Company desires to provide for the form and provisions of the Series X Warrants, the terms upon which they shall be issued
and exercised, and the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders
of the Series X Warrants; and

 

WHEREAS,
all acts and things have been done and performed which are necessary to make the Series X Warrants, when executed on behalf of
the Company and countersigned by or on behalf of the Warrant Agent, as provided herein, the valid, binding and legal obligations
of the Company, and to authorize the execution and delivery of this Agreement.

 

NOW,
THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

 

    	 	 	 

    	 

    

 

1. Appointment
of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the
Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth
in this Agreement.

 

2. Warrants.

 

2.1. Form
of Warrant. Each Warrant shall be issued in registered form only, shall be in substantially the form of Exhibit A hereto,
the provisions of which are incorporated herein and shall be signed by, or bear the facsimile signature of, the Chairman of the
Board or Chief Executive Officer and Treasurer, Secretary or Assistant Secretary of the Company and shall bear a facsimile of
the Company’s seal. In the event the person whose facsimile signature has been placed upon any Warrant shall have ceased
to serve in the capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with the same
effect as if he or she had not ceased to be such at the date of issuance.

 

2.2. Uncertificated
Warrants. Notwithstanding anything herein to the contrary, any Warrant may be issued in uncertificated or book-entry form
through the Warrant Agent and/or the facilities of The Depository Trust Company (the “Depositary”) or other book-entry
depositary system, in each case as determined by the Board of Directors of the Company or by an authorized committee thereof.
Any Warrant so issued shall have the same terms, force and effect as a certificated Warrant that has been duly countersigned by
the Warrant Agent in accordance with the terms of this Agreement.

 

2.3. Effect
of Countersignature. Except with respect to uncertificated Warrants as described above, unless and until countersigned by
the Warrant Agent pursuant to this Agreement, a Warrant shall be invalid and of no effect and may not be exercised by the holder
thereof.

 

    	 	 2	 

    	 

    

 

2.4. Registration.

 

2.4.1. Warrant
Register. The Warrant Agent shall maintain books (“Warrant Register”) for the registration of original issuance
and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and
register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance with instructions
delivered to the Warrant Agent by the Company.

 

2.4.2. Registered
Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and
treat the person in whose name such Warrant shall be registered upon the Warrant Register (“registered holder”) as
the absolute owner of such Warrant and of each Warrant represented thereby (notwithstanding any notation of ownership or other
writing on the Warrant Certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise
thereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

 

3. Terms
and Exercise of Warrants

 

3.1. Warrant
Price. Each Warrant shall, when countersigned by the Warrant Agent, entitle the registered holder thereof, subject to the
provisions of such Warrant and of this Warrant Agreement, to purchase from the Company the number of shares of Common Stock stated
therein, at the price of $6.00 per share, subject to the adjustments provided in Section 4 hereof. The term “Warrant Price”
as used in this Warrant Agreement refers to the price per share at which shares of Common Stock may be purchased at the time a
Warrant is exercised.

 

3.2. Duration
of Warrants. A Warrant may be exercised only during the period (“Exercise Period”) commencing on October 31, 2018
(the “Initial Exercise Date”) and terminating at the close of business on the earlier to occur of (i) April 30, 2024
and (ii) the Redemption Date as provided in Section 6.2 of this Agreement (“Expiration Date”); provided, however,
that the exercise of any Warrant shall be subject to the satisfaction of any applicable conditions, as set forth in Section 7.4
below. Except with respect to the right to receive the Redemption Price (as set forth in Section 6 hereunder), each Warrant not
exercised on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under
this Agreement shall cease at the close of business on the Expiration Date.

 

    	 	 3	 

    	 

    

 

3.3. Exercise
of Warrants.

 

3.3.1. Payment.
Subject to the provisions of the Warrant and this Warrant Agreement, a Warrant, when countersigned by the Warrant Agent, may be
exercised by the registered holder thereof by surrendering it, at the office of the Warrant Agent, or at the office of its successor
as Warrant Agent, in the Borough of Manhattan, City and State of New York, with the subscription form, as set forth in the Warrant,
duly executed, and by paying in full the Warrant Price for each share of Common Stock as to which the Warrant is exercised and
any and all applicable taxes due in connection with the exercise of the Warrant, as follows:

 

(a) good
certified check or good bank draft payable to the order of the Company (or as otherwise agreed to by the Company); or

 

(b) in
the event that, at any time after July 26, 2017, there is no effective registration statement under the Securities Act of 1933,
as amended (the “Securities Act”), registering, or no current prospectus available for, the issuance or resale of
the Warrant Shares by the registered holder of a Warrant, by means of a “cashless exercise,” whereby such Warrant
is surrendered for a number of Warrant Shares equal to:

 

	 	[(A-B)
    * (X)] / (A)
	 	 	 
	 	where:
	 	 	 
	 	(A)
    = 	the
    average of the VWAP for the ten (10) Trading Days immediately preceding the date on which a registered holder elects to exercise
    this Warrant by means of a “cashless exercise”;
	 	 	 
	 	(B)
    = 	the
    Warrant Price; and
	 	 	 
	 	(X)
    = 	the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant
    if such exercise were by means of a cash exercise rather than a cashless exercise.

 

    	 	 4	 

    	 

    

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then
listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:00 p.m. (New York City time)), or (b) in all other cases, the fair market
value of a share of Common Stock as determined by an independent appraiser selected in good faith by registered holders of at
least two-thirds of the then outstanding Warrants and reasonably acceptable to the Company, the fees and expenses of which shall
be paid by the Company.

 

“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the
date in question: the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New
York Stock Exchange, OTCQB, OTCQX or OTCPink (or any successors to any of the foregoing).

 

“Trading
Day” means a day on which the principal Trading Market is open for trading.

 

If
Warrant Shares are issued in such a “cashless exercise,” the parties acknowledge and agree that in accordance with
Section 3(a)(9) of the Securities Act and the holding period of a Warrant may be tacked on to the holding period of the Warrant
Shares for purposes of Rule 144 under the Securities Act. The Company agrees not to take any position contrary to this Section
2(c).

 

    	 	 5	 

    	 

    

 

Notwithstanding
anything herein to the contrary, on the Expiration Date, a Warrant shall be automatically exercised via “cashless exercise”
pursuant to this Section 3.3.1(b). In no event, however, shall any cashless exercise occur if the Warrant Price is greater than
the VWAP which would apply on the Termination Date.

 

3.3.2. Issuance
of Certificates. As soon as practicable after the exercise of any Warrant and the clearance of the funds in payment of the
Warrant Price (if any), the Company shall issue to the registered holder of such Warrant a certificate or certificates for the
number of full shares of Common Stock to which he is entitled, registered in such name or names as may be directed by him, her
or it, and if such Warrant shall not have been exercised in full, a new countersigned Warrant for the number of shares as to which
such Warrant shall not have been exercised. Notwithstanding the foregoing, in no event will the Company be required to net cash
settle the Warrant exercise. Warrants may not be exercised by, or securities issued to, any registered holder in any state in
which such exercise would be unlawful.

 

3.3.3. Valid
Issuance. All shares of Common Stock issued upon the proper exercise of a Warrant in conformity with this Agreement shall
be validly issued, fully paid and nonassessable.

 

3.3.4. Date
of Issuance. Each person in whose name any such certificate for Common Stock is issued shall for all purposes be deemed to
have become the holder of record of such shares on the date on which the Warrant was surrendered and payment of the Warrant Price
was made, irrespective of the date of delivery of such certificate, except that, if the date of such surrender and payment is
a date when the share transfer books of the Company are closed, such person shall be deemed to have become the holder of such
shares at the close of business on the next succeeding date on which the share transfer books are open.

 

    	 	 6	 

    	 

    

 

3.3.5. Delivery
of Warrant Shares Upon Exercise. Warrant Shares purchased under a Warrant shall be transmitted by the Company’s transfer
agent to the registered holder by crediting the account of the registered holder’s or its designee’s balance account
with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is
then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant
Shares to or resale of the Warrant Shares by the registered holder or (B) the Warrant Shares are eligible for resale by the registered
holder without volume or manner-of-sale limitations pursuant to Rule 144 under the Securities Act, and otherwise by physical delivery
of a certificate, registered in the Company’s share register in the name of the registered holder or its designee, for the
number of Warrant Shares to which the registered holder is entitled pursuant to such exercise to the address specified by the
registered holder in the subscription form by the date that is three (3) Trading Days after the delivery to the Warrant Agent
of both the subscription form and the Warrants being exercised (such date, the “Warrant Share Delivery Date”). Within
three (3) Trading Days of the date said subscription form and the Warrants are delivered to the Warrant Agent or, if available,
pursuant to the cashless exercise procedure specified in Section 3.3.1(b) above, the Warrant Shares shall be deemed to have been
issued, and the registered holder or any other person so designated to be named therein shall be deemed to have become a holder
of record of such shares for all purposes, as of the date the Warrants have been exercised, with the Warrant Price and all taxes
due prior to the issuance of such shares, having been paid pursuant to Section 3.3.1. If the Company fails for any reason to deliver
to the registered holder the Warrant Shares subject to the subscription form by the Warrant Share Delivery Date, the Company shall
pay to the registered holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to
such exercise (based on the VWAP of the Common Stock on the date of the applicable subscription form), $10 per Trading Day (increasing
to $20 per Trading Day on the fifth (5th) Trading Day after such liquidated damages begin to accrue) for each Trading Day after
such Warrant Share Delivery Date until such Warrant Shares are delivered or registered holder rescinds such exercise.

 

    	 	 7	 

    	 

    

 

3.3.6. Rescission
Rights. If the Company fails to cause the Transfer Agent to transmit to the registered holder the Warrant Shares pursuant
to Section 3.3.5 by the Warrant Share Delivery Date, then the registered holder will have the right to rescind such exercise.

 

3.3.7.
 Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise.
In addition to any other rights available to the registered holder, if the Company fails for any reason to transmit to a registered
holder the Warrant Shares in accordance with the provisions of Section 3.3.5, and if after such Warrant Share Delivery Date such
registered holder is required by its brokerage firm to purchase (in an open market transaction or otherwise), or the registered
holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by such registered
holder of the Warrant Shares which such registered holder was entitled to receive upon the exercise at issue (a “Buy-In”),
then the Company shall (A) pay in cash to such registered holder (in addition to any other remedies available to or elected by
such registered holder) the amount, if any, by which (x) such registered holder’s total purchase price (including any brokerage
commissions) for the Common Stock so purchased exceeds (y) the product of (1) the aggregate number of shares of Warrant Shares
that such registered holder was entitled to receive from the exercise at issue multiplied by (2) the actual sale price at which
the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and (B) at the option
of such registered holder, either reissue (if surrendered) the Warrants for a number of Warrant Shares equal to the number of
Warrant Shares submitted for exercise (in which case, such exercise shall be deemed rescinded) or deliver to such registered holder
the number of shares of Common Stock that would have been issued if the Company had timely complied with its delivery requirements
under Section 3.3.5. For example, if a registered holder purchases shares of Common Stock having a total purchase price of $11,000
to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with respect to which the actual sale price
of the Warrant Shares (including any brokerage commissions) giving rise to such purchase obligation was a total of $10,000 under
clause (A) of the immediately preceding sentence, the Company shall be required to pay such Holder $1,000. The registered holder
shall provide the Company written notice indicating the amounts payable to such registered holder in respect of the Buy-In and,
upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a registered holder’s right
to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company’s failure to timely deliver Common Stock upon exercise
of the Warrant Shares as required pursuant to the terms hereof.

 

    	 	 8	 

    	 

    

 

4. Adjustments.

 

4.1. Stock
Dividends - Split Ups. If the Company, at any time while the Warrants are outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any Common Stock Equivalents
(which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of the Warrants),
(ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of a reverse
stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues, in the event of a reclassification
of shares of the Common Stock, any shares of capital stock of the Company, then the Warrant Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Company) outstanding
immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately
after such event, and the number of shares issuable upon exercise of a Warrant shall be proportionately adjusted such that the
aggregate Warrant Price of a Warrant shall remain unchanged. Any adjustment made pursuant to this Section 4.1 shall become effective
immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and
shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification. “Common
Stock Equivalents” means any securities of the Company or its subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive,
Common Stock.

 

4.2. Pro
Rata Distributions. During such time as the Warrants are outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of
a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”),
at any time after the issuance of this Warrant, then, in each such case, the registered holder of the Warrants shall be entitled
to participate in such Distribution to the same extent that the registered holders would have participated therein if the registered
holders had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant, immediately before the
date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the participation in such Distribution.

 

    	 	 9	 

    	 

    

 

4.3. Fundamental
Transactions. If, at any time while the Warrants are outstanding, (i) the Company, directly or indirectly, in one or more
related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell,
tender or exchange their shares for other securities, cash or property and has been accepted by the holders of fifty percent (50%)
or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly
or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination
(including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby
such other Person acquires more than fifty percent (50%) of the outstanding shares of Common Stock (not including any shares of
Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons
making or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”),
then, upon any subsequent exercise of a Warrant, the registered holder shall have the right to receive, for each Warrant Share
that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, the number
of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and
any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction
by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental
Transaction. For purposes of any such exercise, the determination of the Warrant Price shall be appropriately adjusted to apply
to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock
in such Fundamental Transaction, and the Company shall apportion the Warrant Price among the Alternate Consideration in a reasonable
manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are
given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be
given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental
Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant and the other
Transaction Documents in accordance with the provisions of this Section 3(i) pursuant to written agreements in form and substance
reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction
and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity
evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding
number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable
and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such
Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value
of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting
the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably
satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity
shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this
Warrant and the other Transaction Documents referring to the “Company” shall refer instead to the Successor Entity),
and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant
and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein. “Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

    	 	 10	 

    	 

    

 

4.4. Notices
of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares issuable upon exercise of a Warrant,
the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from
such adjustment and the increase or decrease, if any, in the number of shares purchasable at such price upon the exercise of a
Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon
the occurrence of any event specified in Sections 4.1 to 4.3, then, in any such event, the Company shall give written notice to
each Warrant holder, at the last address set forth for such holder in the warrant register, of the record date or the effective
date of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event.

 

4.5. No
Fractional Shares. Notwithstanding any provision contained in this Warrant Agreement to the contrary, the Company shall not
issue fractional shares upon exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder
of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company
shall, upon such exercise, round up to the nearest whole number the number of the shares of Common Stock to be issued to the Warrant
holder.

 

    	 	 11	 

    	 

    

 

4.6. Form
of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants issued
after such adjustment may state the same Warrant Price and the same number of shares as is stated in the Warrants initially issued
pursuant to this Agreement; provided, however, that the Company may at any time in its sole discretion make any change in the
form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter
issued or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so
changed.

 

5. Transfer
and Exchange of Warrants.

 

5.1. Registration
of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the Warrant
Register, upon surrender of such Warrant for transfer, properly endorsed with signatures properly guaranteed and accompanied by
appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number of Warrants
shall be issued and the old Warrant shall be cancelled by the Warrant Agent. The Warrants so cancelled shall be delivered by the
Warrant Agent to the Company from time to time upon request.

 

5.2. Procedure
for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, together with a written request for exchange
or transfer, and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the registered
holder of the Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however, that in the event
that a Warrant surrendered for transfer bears a restrictive legend, the Warrant Agent shall not cancel such Warrant and issue
new Warrants in exchange therefor until the Warrant Agent has received an opinion of counsel for the Company stating that such
transfer may be made and indicating whether the new Warrants must also bear a restrictive legend.

 

    	 	 12	 

    	 

    

 

5.3. Fractional
Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which will result in
the issuance of a warrant certificate for a fraction of a warrant.

 

5.4. Service
Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

 

5.5. Warrant
Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the
terms of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever
required by the Warrant Agent, will supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

 

6. Redemption.

 

6.1. Redemption.
At any time after April 30, 2019, the Company, may at its option, redeem all, but not less than all, of the outstanding Warrants
at a price of $0.01 per Warrant (“Redemption Price”); provided, that the:

 

(a)
VWAP of the Common Stock has been at least $18.00 per share (as adjusted for stock splits, stock dividends, or similar events
occurring after the Closing date) for twenty (20) Trading Days out of the thirty (30) Trading Day period ending three (3) business
days prior to the notice of redemption;

 

(b)
average daily trading volume during such thirty (30) Trading Day period is at least 20,000 (as adjusted for stock splits, stock
dividends and similar events) shares; and

 

(c)
a current registration statement under the Securities Act is in effect with respect to the issuance or resale of the Common Stock
underlying the Warrants.

 

    	 	 13	 

    	 

    

 

6.2. Date
Fixed for, and Notice of, Redemption. In the event the Company shall elect to redeem all of the Warrants, the Company shall
fix a date for the redemption. Notice of redemption shall be mailed by first class mail, postage prepaid, by the Company not less
than thirty (30) days prior to the date fixed for redemption (or such longer period of time as may be required by applicable laws
and regulations) to registered holders of the Warrants to be redeemed at their last addresses as they shall appear on the Warrant
Register. Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly given, whether or not
the registered holder received such notice.

 

6.3. Exercise
After Notice of Redemption. The Warrants may be exercised in accordance with Section 3 above at any time after notice of redemption
shall have been given by the Company pursuant to Section 6.2 hereof and prior to the time and date fixed for redemption. On and
after the redemption date, the Holder of this Warrant shall have no further rights except to receive, upon surrender of this Warrant,
the Redemption Price.

 

7. Other
Provisions Relating to Rights of Holders of Warrants.

 

7.1. No
Rights as Shareholder. A Warrant does not entitle the registered holder thereof to any of the rights of a shareholder of the
Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights
to vote or to consent or to receive notice as shareholders in respect of the meetings of shareholders or the election of directors
of the Company or any other matter.

 

7.2. Lost,
Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant
Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated
Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen,
mutilated, or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or
not the allegedly lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

 

    	 	 14	 

    	 

    

 

7.3. Reservation
of Common Stock. The Company shall at all times reserve and keep available a number of its authorized but unissued shares
of Common Stock that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement.

 

7.4. Registration
of Common Stock. The Company agrees to use its commercially reasonable best efforts to have an effective and current registration
statement, whether as a post-effective amendment to the Registration Statement or a new registration statement, for the registration,
under the Act, of issuance or resale of the shares of Common Stock issuable upon exercise of the Warrants. In either case, the
Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration
statement until the expiration of the Warrants in accordance with the provisions of this Agreement. In addition, the Company agrees
to use its commercially reasonable best efforts to register such securities under the blue sky laws of the states of residence
of the exercising warrant holders to the extent an exemption is not available. If any such post-effective amendment or registration
statement has not been declared effective at a time while the Warrants are exercisable, holders of the Warrants shall have the
right, until such time as such post-effective amendment or registration statement has been declared effective by the SEC, and
during any other period after such date of effectiveness when the Company shall fail to have maintained an effective registration
statement covering the shares of Common Stock issuable upon exercise of the Warrants, to exercise such Warrants on a “cashless
basis” as determined in accordance with Section 3.3.1(b). For the avoidance of any doubt, unless and until all of the Warrants
have been exercised on a “cashless basis,” the Company shall continue to be obligated to comply with its registration
obligations under this Section 7.4.

 

8. Concerning
the Warrant Agent and Other Matters.

 

8.1. Payment
of Taxes. The Company will from time to time promptly pay all taxes and charges that may be imposed upon the Company or the
Warrant Agent in respect of the issuance or delivery of shares of Common Stock upon the exercise of Warrants, but the Company
shall not be obligated to pay any transfer taxes in respect of the Warrants or such shares.

 

    	 	 15	 

    	 

    

 

8.2. Resignation,
Consolidation, or Merger of Warrant Agent.

 

8.2.1. Appointment
of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged
from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the
office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing
a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of
30 days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of the Warrant
(who shall, with such notice, submit his Warrant for inspection by the Company), then the holder of any Warrant may apply to the
Supreme Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s
cost. Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation organized and existing
under the laws of the State of New York, in good standing and having its principal office in the Borough of Manhattan, City and
State of New York, and authorized under such laws to exercise corporate trust powers and subject to supervision or examination
by federal or state authority. After appointment, any successor Warrant Agent shall be vested with all the authority, powers,
rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect as if originally named as Warrant
Agent hereunder, without any further act or deed; but if for any reason it becomes necessary or appropriate, the predecessor Warrant
Agent shall execute and deliver, at the expense of the Company, an instrument transferring to such successor Warrant Agent all
the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request of any successor Warrant Agent
the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting
in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties, and obligations.

 

8.2.2. Notice
of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof
to the predecessor Warrant Agent and the transfer agent for the Common Stock not later than the effective date of any such appointment.

 

    	 	 16	 

    	 

    

 

8.2.3. Merger
or Consolidation of Warrant Agent. Any corporation into which the Warrant Agent may be merged or with which it may be consolidated
or any corporation resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor
Warrant Agent under this Agreement without any further act.

 

8.3. Fees
and Expenses of Warrant Agent.

 

8.3.1. Remuneration.
The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder and will
reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in the execution of its
duties hereunder.

 

8.3.2. Further
Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged,
and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent
for the carrying out or performing of the provisions of this Agreement.

 

8.4. Liability
of Warrant Agent.

 

8.4.1. Reliance
on Company Statement. Whenever in the performance of its duties under this Warrant Agreement, the Warrant Agent shall deem
it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action
hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be
conclusively proved and established by a statement signed by the Chief Executive Officer or Chairman of the Board of the Company
and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any action taken or suffered in good faith
by it pursuant to the provisions of this Agreement.

 

    	 	 17	 

    	 

    

 

8.4.2. Indemnity.
The Warrant Agent shall be liable hereunder only for its own gross negligence, willful misconduct or bad faith. The Company agrees
to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, costs and reasonable
counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Agreement except as a result of the Warrant
Agent’s gross negligence, willful misconduct, or bad faith.

 

8.4.3. Exclusions.
The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity
or execution of any Warrant (except its countersignature thereof); nor shall it be responsible for any breach by the Company of
any covenant or condition contained in this Agreement or in any Warrant; nor shall it be responsible to make any adjustments required
under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment or the ascertaining
of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make any representation
or warranty as to the authorization or reservation of any Common Stock to be issued pursuant to this Agreement or any Warrant
or as to whether any Common Stock will when issued be valid and fully paid and nonassessable.

 

8.5. Acceptance
of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the
terms and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised
and concurrently account for, and pay to the Company, all moneys received by the Warrant Agent for the purchase of Common Stock
through the exercise of Warrants.

 

9. Miscellaneous
Provisions.

 

9.1. Successors.
All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure
to the benefit of their respective successors and assigns.

 

    	 	 18	 

    	 

    

 

9.2. Notices.
Any notice, statement or demand authorized by this Warrant Agreement to be given or made by the Warrant Agent or by the holder
of any Warrant to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or, if sent
by certified mail or private courier service, within five days after deposit of such notice, statement or demand, postage prepaid,
addressed (until another address is filed in writing by the Company with the Warrant Agent), as follows:

 

PAVmed
Inc.

One
Grand Central Place, Suite 4600

New York, New York 10165

Attn:
Chief Executive Officer

 

Any
notice, statement or demand authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to
or on the Warrant Agent shall be sufficiently given when so delivered if by hand or overnight delivery or, if sent by certified
mail or private courier service within five days after deposit of such notice, statement or demand, postage prepaid, addressed
(until another address is filed in writing by the Warrant Agent with the Company), as follows:

 

Continental
Stock Transfer & Trust Company

1
State Street Plaza, 30th Floor

New
York, New York 10004

Attn:
Compliance Department

 

with
a copy in each case to:

 

Graubard
Miller

The
Chrysler Building

405
Lexington Avenue

New
York, New York 10174

Attn:
David Alan Miller, Esq.

 

9.3. Applicable
Law. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in all respects
by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application
of the substantive laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim against it arising
out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United
States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction
shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient
forum. Any such process or summons to be served upon the Company may be served by transmitting a copy thereof by registered or
certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section 9.2 hereof. Such
mailing shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding or claim.

 

    	 	 19	 

    	 

    

 

9.4. Persons
Having Rights under this Agreement. Nothing in this Agreement expressed and nothing that may be implied from any of the provisions
hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties hereto
and the registered holders of the Warrants, any right, remedy, or claim under or by reason of this Warrant Agreement or of any
covenant, condition, stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements
contained in this Warrant Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and
assigns and of the registered holders of the Warrants.

 

9.5. Examination
of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the Warrant
Agent in the Borough of Manhattan, City and State of New York, for inspection by the registered holder of any Warrant. The Warrant
Agent may require any such holder to submit his Warrant for inspection by it.

 

9.6. Counterparts.
This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all
purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

    	 	 20	 

    	 

    

 

9.7. Effect
of Headings. The Section headings herein are for convenience only and are not part of this Warrant Agreement and shall not
affect the interpretation thereof.

 

9.8 Amendments.
This Agreement may not be amended by the parties hereto without the written consent or vote of the registered holders of Warrants
representing at least two-thirds of the Common Stock issuable upon exercise of all outstanding Warrants.

 

9.9 Severability.
This Warrant Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall
not affect the validity or enforceability of this Warrant Agreement or of any other term or provision hereof. Furthermore, in
lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of
this Warrant Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid
and enforceable.

 

    	 	 21	 

    	 

    

 

 IN
WITNESS WHEREOF, this Agreement has been duly executed by the parties hereto as of the day and year first above written.

 

	 	PAVMED
    INC.
	 	 	 
	 	By:	 
	 	Name:
	 
	 	Title:
	 
	 	 	                          
	 	CONTINENTAL
    STOCK TRANSFER  & TRUST COMPANY
	 	 	 
	 	By:	 
	 	Name:
	 
	 	Title:
	 

 

    	 	 22Exhibit
10.1

 

10%
UNSECURED PROMISSORY NOTE

 

	$32,500	June 15, 2017
	 	(“Original
    Issue Date”)

 

FOR
VALUE RECEIVED, HealthLynked Corporation, a Nevada Corporation (the “Maker” or the “Company”),
with its primary office located at 1726 Medical Blvd, Suite 101 Naples Florida 34110 promises to pay to the order of Michael Dent
(the “Payee”) or his registered assigns (with the Payee, the “Holder”), upon the terms set
forth below, the principal sum of $32,500, plus interest on the unpaid principal sum outstanding at the rate of 10% per annum
(this “Note”).

 

1.             Payments.

 

(a)           Principal shall bear interest at the rate of 10% per annum from the Original Issue Date until paid in full. Unless an Event of
Default shall have previously occurred and be continuing, or the Note is earlier paid in full, the principal and accrued and unpaid
interest thereon shall be payable by June 16, 2018 (the “Maturity Date”). All payments hereunder shall be first
credited against any accrued and unpaid interest, with remaining amounts credited towards unpaid principal.

 

(b)           Following an Event of Default, interest shall accrue and be payable under this Note until paid in full at a default interest rate
equal to 15% per annum on all unpaid principal and interest on this Note (or such lower maximum amount of interest permitted to
be charged under applicable law) (the “Default Rate”) which will accrue daily, from the date such principal
and/or interest is due hereunder through and including the date of payment.

 

(c)           The Maker may prepay the principal and accrued and unpaid interest at any time without penalty.

 

2.             Unsecured Obligation. The obligations of the Maker under this Note are unsecured obligations of Maker.

 

3.             Events of Default.

 

(a)           “Event of Default”, wherever used herein, means any one of the following events (whatever the reason and whether
it shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court,
or any order, rule or regulation of any administrative or governmental body):

 

(i)           any default in the payment of the principal of, or the interest on, this Note, as and when the same shall become due and payable;

 

(ii)           Maker shall fail to observe or perform any obligation or shall breach any term or provision of this Note and such failure or breach
shall not have been remedied within ten (10) business days after the date on which notice of such failure or breach shall have
been delivered (other than those occurrences described in other provisions of this Section 3 for which a different grace or cure
period is specified, or for which no cure period is specified and which constitute immediate Events of Default);

 

     

     

    

 

(iii)           Maker shall fail to observe or perform any of its material obligations owed to the Holder or any other material covenant, agreement,
representation or warranty contained in, or otherwise commit any material breach hereunder or in any other agreement executed
in connection herewith;

 

(iv)           Maker shall commence, or there shall be commenced against the Maker a case under any applicable bankruptcy or insolvency laws
as now or hereafter in effect or any successor thereto, or the Maker commences any other proceeding under any reorganization,
arrangement, adjustment of debt, relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction
whether now or hereafter in effect relating to the Maker, or there is commenced against the Maker any such bankruptcy, insolvency
or other proceeding which remains un-dismissed for a period of sixty (60) days; or the Maker is adjudicated insolvent or bankrupt;
or any order of relief or other order approving any such case or proceeding is entered; or the Maker suffers any appointment of
any custodian or the like for it or any substantial part of its property which continues undischarged or unstayed for a period
of 60 days; or the Maker makes a general assignment for the benefit of creditors; or the Maker shall fail to pay, or shall state
that it is unable to pay, or shall be unable to pay, its debts generally as they become due; or the Maker shall call a meeting
of its creditors with a view to arranging a composition, adjustment or restructuring of its debts; or the Maker shall by any act
or failure to act expressly indicate its consent to, approval of or acquiescence in any of the foregoing; or any corporate or
other action is taken by the Maker for the purpose of effecting any of the foregoing; or

 

(v)           Maker shall default in any of its respective obligations under any mortgage, credit agreement or other facility, indenture agreement,
factoring agreement or other instrument under which there may be issued, or by which there may be secured or evidenced any indebtedness
for borrowed money or money due under any long term leasing or factoring arrangement of the Maker, whether such indebtedness now
exists or shall hereafter be created and such default shall result in indebtedness aggregating more than $5,000 becoming or being
declared due and payable prior to the date on which it would otherwise become due and payable.

 

(b)           If any Event of Default occurs and shall be continuing, the full principal amount of this Note, together with all accrued interest
thereon, shall become, at the Holder’s election, immediately due and payable in cash.

 

(c)           The Holder need not provide and the Maker hereby waives any presentment, demand, protest or other notice of any kind, and the
Holder may immediately and without expiration of any grace period enforce any and all of its rights and remedies hereunder and
all other remedies available to it under applicable law. Such declaration may be rescinded and annulled by the Holder at any time
prior to payment hereunder. No such rescission or annulment shall affect any subsequent Event of Default or impair any right consequent
thereon.

 

4.           Negative Covenants. So long as any portion of this Note is outstanding, unless adequate provision for repayment of this
Note is made in connection with such action, the Maker will not directly or indirectly:

 

(a)           other than Permitted Indebtedness, enter into, create, incur, assume, guarantee or suffer to exist any indebtedness for borrowed
money of any kind, including but not limited to, a guarantee, on or with respect to any of its property or assets now owned or
hereafter acquired or any interest therein or any income or profits therefrom;

 

    	 	2	 

     

    

 

(b)           other than Permitted Liens, enter into, create, incur, assume or suffer to exist any liens of any kind, on or with respect to
any of its property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom;

 

(c)           amend its articles of formation, articles of organization or other charter documents so as to adversely affect any rights of the
Holder;

 

(d)           sell, mortgage, assign, transfer, license or otherwise dispose of any business, property or assets of the Company now owned or
hereafter acquired (other than in the ordinary course of business consistent with past practice); or

 

(e)           enter into any agreement with respect to any of the foregoing.

 

“Permitted
Indebtedness” shall mean either (a) the indebtedness of the Maker existing on the date of issuance of this Note, and
(b) any indebtedness the proceeds of which are used to repay the Note in full after giving of appropriate notice as set forth
in Section 1(d) above and (c) any indebtedness incurred in the ordinary course of business or consented to by holders a majority
of the outstanding principal and interest on the Notes, which consent shall be binding upon the Holder.

 

“Permitted
Lien” shall mean the individual and collective reference to the following: (a) liens for taxes, assessments and other
governmental charges or levies not yet due or liens for taxes, assessments and other governmental charges or levies being contested
in good faith and by appropriate proceedings for which adequate reserves (in the good faith judgment of the management of the
Maker) have been established in accordance with generally accepted accounting procedures, (b) liens imposed by law which were
incurred in the ordinary course of business, such as carriers’, warehousemen’s and mechanics’ liens, statutory
landlords’ liens, and other similar liens arising in the ordinary course of business, and (x) which do not individually
or in the aggregate materially detract from the value of such property or assets or materially impair the use thereof in the operation
of the business of the Maker or (y) which are being contested in good faith by appropriate proceedings, which proceedings have
the effect of preventing the forfeiture or sale of the property or asset subject to such lien, and (c) purchase money security
interests.

 

5.             No Waiver of the Holder’s Rights. All payments of principal and interest shall be made without setoff, deduction
or counterclaim. No delay or failure on the part of the Holder in exercising any of its options, powers or rights, nor any partial
or single exercise of its options, powers or rights shall constitute a waiver thereof or of any other option, power or right,
and no waiver on the part of the Holder of any of its options, powers or rights shall constitute a waiver of any other option,
power or right. Maker hereby waives presentment of payment, protest, and all notices or demands in connection with the delivery,
acceptance, performance, default or endorsement of this Note. Acceptance by the Holder of less than the full amount due and payable
hereunder shall in no way limit the right of the Holder to require full payment of all sums due and payable hereunder in accordance
with the terms hereof.

 

    	 	3	 

     

    

 

6.            Modifications. No term or provision contained herein may be modified, amended or waived except by written agreement or
consent signed by the party to be bound thereby.

 

7.            Cumulative Rights and Remedies; Usury. The rights and remedies of the Holder expressed herein are cumulative and not exclusive
of any rights and remedies otherwise available under this Note, or applicable law (including at equity). The election of the Holder
to avail itself of any one or more remedies shall not be a bar to any other available remedies, which the Maker agrees the Holder
may take from time to time. If it shall be found that any interest due hereunder shall violate applicable laws governing usury,
the applicable rate of interest due hereunder shall be reduced to the maximum permitted rate of interest under such law.

 

8.            Severability. If any provision of this Note is declared by a court of competent jurisdiction to be in any way invalid,
illegal or unenforceable, the balance of this Note shall remain in effect, and if any provision is inapplicable to any person
or circumstance, it shall nevertheless remain applicable to all other persons and circumstances. If it shall be found that any
interest or other amount deemed interest due hereunder shall violate applicable laws governing usury, the applicable rate of interest
due hereunder shall automatically be lowered to equal the maximum permitted rate of interest.

 

9.             Successors and Assigns. This Note shall be binding upon the Maker and its successors and shall inure to the benefit of
the Holder and its successors and assigns. The term “Holder” as used herein, shall also include any endorsee,
assignee or other holder of this Note.

 

10.          Lost or Stolen Promissory Note. If this Note is lost, stolen, mutilated or otherwise destroyed, the Maker shall execute
and deliver to the Holder a new promissory note containing the same terms, and in the same form, as this Note. In such event,
the Maker may require the Holder to deliver to the Maker an affidavit of lost instrument and customary indemnity in respect thereof
as a condition to the delivery of any such new promissory note.

 

11.          Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Note shall be
governed by and construed and enforced in accordance with the internal laws of the State of Florida, without regard to the principles
of conflicts of law thereof. Each of the Maker and the Holder agree that all legal proceedings concerning the interpretations,
enforcement and defense of this Note shall be commenced in the state and federal courts sitting in the City of Miami (the “Miami
Courts”). Each of the Maker and the Holder hereby irrevocably submit to the exclusive jurisdiction of the Miami Courts
for the adjudication of any dispute hereunder (including with respect to the enforcement of this Note), and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction
of any such court, that such suit, action or proceeding is improper. Each of the Maker and the Holder hereby irrevocably waive
personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof
via registered or certified mail or overnight delivery (with evidence of delivery) to the other at the address in effect for notices
to it under this Note and agrees that such service shall constitute good and sufficient service of process and notice thereof.
Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Each of
the Maker and the Holder hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial
by jury in any legal proceeding arising out of or relating to this Note or the transactions contemplated hereby.

 

    	 	4	 

     

    

 

12.             Maker shall pay to the Holder, on demand, the amount of any and all reasonable expenses, including, without limitation, attorneys’
fees, and legal expenses, which the Holder may incur in connection with (a) enforcement or collection of this Note following and
Event of Default; (b) exercise or enforcement of any the rights, remedies or powers of the Holder hereunder or with respect to
any or all of the obligations under this Note upon breach or threatened breach; or (c) failure by Maker to perform and observe
any agreements of Maker contained herein.

 

13.             Notice. Whenever notice is required to be given under this Note, unless otherwise provided herein, such notice shall be
given in accordance with the last known address of the party to receive such Notice.

 

14.             Required Notice to the Holder. The Holder is to be notified by the Maker, within five (5), business days, in accordance
with Section 13, of the existence or occurrence, of any Event of Default.

 

[signature
page follows]

 

    	 	5	 

     

    

 

IN
WITNESS WHEREOF, Maker has caused this Note to be signed in its name by its duly authorized officer as of the Issue Date first
set forth above.

  

	 	HealthLynked
    Corporation  
	 	 
	 	By:
    	/s/
    George O’Leary
	 	 	Name:
     George O’Leary
	 	 	Title:
       Chief Financial Officer

 

 

6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}]]